Value Bridge — NEW YORK PRESBYTERIAN HOSPITAL
Current $-104M → Target $66M (+$170.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-103.8M
Current EBITDA
$66.1M
Target EBITDA
+$170.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$38.5M
Payer Mix Optimization
$92.3M
Cost to Collect Reduction
$30.8M
Clean Claim Improvement
$23.1M
Volume & Rate Growth
$153.8M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-104M to $66M. The highest-impact lever is Volume & Rate Growth at $61.5M probability-weighted.
IC talking point: "We see $170M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $1870M in equity value creation."